$ARNA Recent News Arena shares surge as marketer doubles

New Post Public Reply Private Reply Replies (0) Message Board

Jan 18, 2014 at 12:46 AM

$ARNA Recent News

Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com

Arena's Belviq Scripts Showing Traction - Vivus As Well 1:52 p.m. Jan. 17, 2014 - Seeking Alpha
Arena Pharmaceuticals - Why I Believe It Is The Next Major Biotech 9:21 a.m. Jan. 16, 2014 - Seeking Alpha
Arena Pharmaceuticals (ARNA) in Focus: Stock Rallies 7.2% - Tale of the Tape 8:44 a.m. Jan. 16, 2014 - Zacks.com
Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Year 4:02 a.m. Jan. 15, 2014 - Seeking Alpha
J.P. Morgan Healthcare Confab Live Blog: Day One 10:19 a.m. Jan. 13, 2014 - TheStreet.com
Arena Marches Up - Belviq Sales Show Traction 3:07 p.m. Jan. 10, 2014 - Seeking Alpha
Healthcare Picks By Drug Type In 2014 8:59 a.m. Jan. 9, 2014 - Seeking Alpha
FDA Action Date for Orexigen's Contrave - Analyst Blog 5:20 p.m. Jan. 8, 2014 - Zacks.com
Orexigen Receives Good News From FDA 2:36 p.m. Jan. 7, 2014 - Seeking Alpha
Arena's Belviq Closes Out 2013; Begins 2014 12:39 a.m. Jan. 7, 2014 - Seeking Alpha
Obesity Stocks Focus On Approvals As Arena Pharmaceuticals Goes Global 5:09 p.m. Jan. 6, 2014 - TheStreet.com
Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Jan. 3, 2014 - 247WallSt.com
What Lies Ahead For Arena Pharmaceutical? 1:42 p.m. Jan. 2, 2014 - Seeking Alpha
What Lies Ahead For Arena Pharmaceuticals? 1:42 p.m. Jan. 2, 2014 - Seeking Alpha
Vivus Scores Insurance Win 12:09 p.m. Jan. 2, 2014 - Seeking Alpha
February 7th Options Now Available For Arena Pharmaceuticals (ARNA) 11:52 a.m. Jan. 2, 2014 - TheStreet.com
SA PRO: Top Long And Short Ideas, Tuesday December 31 7:30 a.m. Jan. 1, 2014 - Seeking Alpha
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Belviq Sales Closing Out Year Modestly - Surprises Soon For Arena? 5:21 p.m. Dec. 27, 2013 - Seeking Alpha
Arena Pharmaceuticals - A 2014 Story 4:14 p.m. Dec. 26, 2013 - Seeking Alpha

Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 8:00 a.m. Jan. 9, 2014 - PR Newswire
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 6, 2014 - PR Newswire
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals 8:00 a.m. Dec. 31, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Insiders Trend Analysis: Tiger Oil and Energy Inc, Groupon Inc, General Motors Company Arena Pharmaceuticals 10:46 a.m. Dec. 19, 2013 - ACCESSWIRE
Opening Buzzers: General Motors Company, Sunedison Inc, Nokia Corporation, Arena Pharmaceuticals 10:11 a.m. Dec. 17, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co 9:17 a.m. Dec. 6, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Notable News Of The Day: BlackBerry Ltd, Arena Pharmaceuticals, Groupon Inc, Zynga Inc 9:56 a.m. Dec. 2, 2013 - ACCESSWIRE
Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 8:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 8:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 8:49 a.m. Nov. 26, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Geron Corp., Incyte Corp., and Spectrum Pharma Inc. 1:31 p.m. Nov. 22, 2013 - PR Newswire
Health Care Initiatives, Clinical Data Presentations, Public Offerings, Contract Extensions and Publication of Pre-Clinical Study - Research Report on Cigna, Arena, Synta, Healthways, and Catalyst 8:00 a.m. Nov. 21, 2013 - PR Newswire
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at American Heart Association 2013 Scientific Sessions 8:00 a.m. Nov. 18, 2013 - PR Newswire
BELVIQ® (lorcaserin HCl) CIV Data Featured in Five Abstracts to be Presented at ObesityWeek(SM) 2013 4:05 p.m. Nov. 13, 2013 - PR Newswire
Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Nov. 12, 2013 - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:14 a.m. Nov. 11, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Research on EGY, GLER, PGLO, and ARNA 12:16 a.m. Nov. 11, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RepData's New Platform Redefines Market Research Game

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Duni AB's 2027 AGM: Strategic Moves Amid Challenges

Navigating Choppy Waters: Duni's Market Stance Ever have one of those days when the market just refuses to cooperate no matter how much you hustle? Duni AB knows the feeling all too well. As this Swedish outfit gears up for its 2027 AGM, they're grinding through an array of challenges as prickly as a porcupine. Here's the scoop: their interim report from earlier this year...

Alfa Laval's Market Outlook: Strategic Plans Ahead

Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...

Svea Mining Taps DNB Carnegie to Boost Liquidity

Mining Moves and Market Churn Dusted off my boots and took a gander at Svea Mining AB. They’re a Swedish outfit that's rustling up some gold, copper, and silver out in the wilds of Northern Sweden. Now, they've got DNB and Carnegie stepping in as liquidity providers. Let me chew on this for a minute—why does a miner need a liquidity provider, you ask? It’s all about...

Boston Scientific's SIMPLAAFY Trial Promises Post-Op Ease

SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...

FirstEnergy Foundation Aims High with New Leadership

Changing the Guard at FirstEnergy Foundation For a company with a hefty footprint across the northeastern United States, FirstEnergy Corp. (NYSE: FE) seems to be diving deep into the philanthropic pool with its recent leadership shuffle. Don Rettig, an experienced figure in the world of corporate philanthropy, is taking the helm as Vice President and President of the...

Camect and 3Si Partnership: Revolutionizing Public Safety

Smarter Surveillance with Camect and 3Si A fresh collaboration is stirring the security pot, straight from Silicon Valley's buzzing tech nest. Camect, the brainiacs behind AI-powered video smarts, are shaking hands with 3Si Security Systems. In plain talk, they're hooking up Camect's sharp-eyed video tech with 3Si's DirectToDispatch™ system. This ain’t some techie...

Elron Ventures Revamps Leadership to Boost Tech Focus

Shaking Up the Leadership Roster The folks over at Elron Ventures are making some big moves, shifting the chess pieces on their leadership board in a bid to bolster their investment and M&A strategy. They're bringing in fresh blood and seasoned vets alike to navigate the rocky waters of Defense Tech, Deep Tech, Cybersecurity, and AI. You reckon they're onto something,...

Platinum Equity's Bold Move on Warren Valve: An Analysis

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

Johns Hopkins Teams with Prospect HQ for Athlete Careers

Snagging a career after college isn't quite as easy as catching a football, but the folks over at Johns Hopkins University Athletics and Prospect HQ seem to think they have a playbook for it. You might raise an eyebrow hearing this, but Prospect HQ has now roped in student-athletes from over 500 colleges and universities nationwide into its talent pool. That's a hefty...